BIOMARIN PHARMACEUTICAL INC.
BMRN · NASDAQ
BioMarin is a global biotechnology company that develops and commercializes innovative therapies for serious and life-threatening rare and ultra-rare genetic diseases. The Company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.
ESG Scores
Overall ESG4.3
Environmental5.6
Social3.6
Governance5.1
Gender Diversity
Female Directors0.2727%
Female Executives0.0746268656716418%
Women in Workforce0.5%
CEO GenderMale